Haematological malignancies, commonly known as blood cancers, encompass a diverse group of diseases affecting the blood, bone ...

The following is a summary of “Prophylactic versus restrictive platelet transfusion strategy in patients with haematological malignancies in the ICU setting, a propensity-score analysis,” published in ...

The ANGELICA Trial evaluates allogeneic NKG2DL-targeting chimeric antigen receptor-grafted gamma delta T cells in patients with advanced solid tumours or haematological malignancies. Refer to Form 6K ...

Objective: Patients receiving cancer treatments commonly experience haematological adverse effects (AEs) related to chemotherapy or molecularly targeted therapies, which may be associated with ...

However, clozapine poses significant haematological risks, notably agranulocytosis, necessitating stringent blood monitoring protocols. Methods: This study examined haematological parameters in 157 ...

Haematological malignancies are the types of cancer affecting blood, bone marrow and lymph nodes. They are referred to as leukaemia, lymphoma and myeloma depending on the type of cell affected.

Establishing an accurate diagnosis and classification of haematological malignancies (blood cancers) relies on a spectrum of molecular diagnostic tests to evaluate chromosomal and nucleotide ...